Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced the completion of its full audit and financial review, which was conducted by Seale & Beers Certified Public Accounts, LLC.

"I am pleased that the audit has now been completed and that we are moving toward full reporting status with the U.S. Securities & Exchange Commission. We are excited about the future for Biomagnetics and we want to make sure all of our investors and shareholders have full transparency into our operations," commented Clayton Hardman, CEO of Biomagnetics.

About Biomagnetics Diagnostics Corp.

Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company and an acquirer of other innovative technologies. More information on Biomagnetics Diagnostics Corp. can be seen at www.biomagneticsbmgp.com.

Biomagnetics Diagnostics (CE) (USOTC:BMGP)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025 Biomagnetics Diagnostics (CE) 차트를 더 보려면 여기를 클릭.
Biomagnetics Diagnostics (CE) (USOTC:BMGP)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025 Biomagnetics Diagnostics (CE) 차트를 더 보려면 여기를 클릭.